Caveolae and the caveolins in human disease

被引:18
作者
Campbell, L [1 ]
Gumbleton, M
Ritchie, K
机构
[1] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3XF, S Glam, Wales
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
关键词
caveolin; caveolae; disease; cancer; atherosclerosis; Alzheimer's disease; diabetes; muscular dystrophy; inflammation;
D O I
10.1016/S0169-409X(01)00145-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There has been an exponential growth in caveolae research since the early 1990s. The caveolae membrane system comprises unique lipid and protein domains, and fulfills a role in a wide range of processes. At the plasma membrane caveolae serve to compartmentalise and integrate a wide range of signal transduction processes. A key structural and functional protein for caveolae is caveolin. Caveolin proteins possess a 'scaffolding' domain which for caveolins-1 and -3 appear central to many of the reported signal regulation functions for caveolae. Caveolae or caveolin protein are increasingly implicated in the molecular pathology of a number of diseases. Opportunities exist for basic and applied investigators working within the pharmaceutical sciences to exploit the caveolae membrane system to identify novel pharmacological targets and therapeutic strategies, including the delivery of pharmacologically active caveolin based peptides. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:325 / 335
页数:11
相关论文
共 66 条
[41]   HYPERCHOLESTEROLEMIA INCREASES ENDOTHELIAL SUPEROXIDE ANION PRODUCTION [J].
OHARA, Y ;
PETERSON, TE ;
HARRISON, DG .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2546-2551
[42]  
PALADE GE, 1961, CIRCULATION, V24, P368
[43]  
Peterson TE, 1999, CIRC RES, V85, P29
[44]   Reduction of caveolin 1 gene expression in lung carcinoma cell lines [J].
Racine, C ;
Bélanger, M ;
Hirabayashi, H ;
Boucher, M ;
Chakir, J ;
Couet, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (03) :580-586
[45]  
Razani B, 2000, J CELL SCI, V113, P2103
[46]   Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy [J].
Repetto, S ;
Bado, M ;
Broda, P ;
Lucania, G ;
Masetti, E ;
Sotgia, F ;
Carbone, I ;
Pavan, A ;
Bonilla, E ;
Cordone, G ;
Lisanti, MP ;
Minetti, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (03) :547-550
[47]   OXYGEN-DERIVED FREE-RADICALS, ENDOTHELIUM, AND RESPONSIVENESS OF VASCULAR SMOOTH-MUSCLE [J].
RUBANYI, GM ;
VANHOUTTE, PM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 250 (05) :H815-H821
[48]   RNA GENETICS OF BREAST-CANCER - MASPIN AS PARADIGM [J].
SAGER, R ;
SHENG, S ;
ANISOWICZ, A ;
SOTIROPOULOU, G ;
ZOU, Z ;
STENMAN, G ;
SWISSHELM, K ;
CHEN, Z ;
HENDRIX, MJC ;
PEMBERTON, P ;
RAFIDI, K ;
RYAN, K .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 :537-546
[49]   INDUCTION OF CAVEOLIN DURING ADIPOGENESIS AND ASSOCIATION OF GLUT4 WITH CAVEOLIN-RICH VESICLES [J].
SCHERER, PE ;
LISANTI, MP ;
BALDINI, G ;
SARGIACOMO, M ;
MASTICK, CC ;
LODISH, HF .
JOURNAL OF CELL BIOLOGY, 1994, 127 (05) :1233-1243
[50]   Caveolins in cholesterol trafficking and signal transduction: Implications for human disease [J].
Schlegel, A ;
Pestell, RG ;
Lisanti, MP .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2000, 5 :D929-D937